Structure and Activity of Human Mitochondrial Peptide Deformylase, a Novel Cancer Target

Journal of Molecular Biology

Volumn 387, Issue 5, 2009, Pages 1211-1228

  Escobar Alvarez, Sindy ^a,b   Goldgur, Yehuda ^c   Yang, Guangli ^a   Ouerfelli, Ouathek ^a   Li, Yueming ^a   Scheinberg, David A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Weill Cornell Graduate School of Biomedical Sciences   (United States)

^c NEW YORK STRUCTURAL BIOLOGY CENTER   (United States)

Author keywords

crystal structure; human deformylase; peptide deformylase

Indexed keywords

ACTINONIN; MITOCHONDRIAL PROTEIN; PEPTIDE DEFORMYLASE;

ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; ENZYME KINETICS; ENZYME STRUCTURE; HUMAN; MAMMAL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE;

MAMMALIA;

EID: 63749099831     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2009.02.032     Document Type: Article

References (57)

1. Mazel D., Pochet S., and Marliere P. Genetic characterization of polypeptide deformylase, a distinctive enzyme of eubacterial translation. EMBO J. 13 (1994) 914-923
2. Serero A., Giglione C., Sardini A., Martinez-Sanz J., and Meinnel T. An unusual peptide deformylase features in the human mitochondrial N-terminal methionine excision pathway. J. Biol. Chem. 278 (2003) 52953-52963
3. Takeuchi N., Kawakami M., Omori A., Ueda T., Spremulli L.L., and Watanabe K. Mammalian mitochondrial methionyl-tRNA transformylase from bovine liver. Purification, characterization, and gene structure. J. Biol. Chem. 273 (1998) 15085-15090
4. Takeuchi N., Vial L., Panvert M., Schmitt E., Watanabe K., Mechulam Y., and Blanquet S. Recognition of tRNAs by methionyl-tRNA transformylase from mammalian mitochondria. J. Biol. Chem. 276 (2001) 20064-20068
5. Giglione C., Serero A., Pierre M., Boisson B., and Meinnel T. Identification of eukaryotic peptide deformylases reveals universality of N-terminal protein processing mechanisms. EMBO J. 19 (2000) 5916-5929
6. Lee M.D., Antczak C., Li Y., Sirotnak F.M., Bornmann W.G., and Scheinberg D.A. A new human peptide deformylase inhibitable by actinonin. Biochem. Biophys. Res. Commun. 312 (2003) 309-315
7. Lee M.D., She Y., Soskis M.J., Borella C.P., Gardner J.R., Hayes P.A., et al. Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics. J. Clin. Invest. 114 (2004) 1107-1116
8. Howard M.H., Cenizal T., Gutteridge S., Hanna W.S., Tao Y., and Totrov M. A novel class of inhibitors of peptide deformylase discovered through high-throughput screening and virtual ligand screening. J. Med. Chem. 47 (2004) 6669-6672
9. Leeds J.A., and Dean C.R. Peptide deformylase as an antibacterial target: a critical assessment. Curr. Opin. Pharmacol. 6 (2006) 445-452
10. Watters A.A., Jones R.N., Leeds J.A., Denys G., Sader H.S., and Fritsche T.R. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004). J. Antimicrob. Chemother. 57 (2006) 914-923
11. Lofland D., Difuntorum S., Waller A., Clements J.M., Weaver M.K., Karlowsky J.A., and Johnson K. In vitro antibacterial activity of the peptide deformylase inhibitor BB-83698. J. Antimicrob. Chemother. 53 (2004) 664-668
12. Teo J.W.P., Thayalan P., Beer D., Yap A.S.L., Nanjundappa M., Ngew X., et al. Peptide deformylase inhibitors as potent antimycobacterial agents. Antimicrob. Agents Chemother. 50 (2006) 3665-3673
13. Spencer A.C., and Spremulli L.L. Interaction of mitochondrial initiation factor 2 with mitochondrial fMet-tRNA. Nucleic Acids Res. 32 (2004) 5464-5470
14. Liao H.X., and Spremulli L.L. Identification and initial characterization of translational initiation factor 2 from bovine mitochondria. J. Biol. Chem. 265 (1990) 13618-13622
15. Nguyen K.T., Hu X., Colton C., Chakrabarti R., Zhu M.X., and Pei D. Characterization of a human peptide deformylase: implications for antibacterial drug design. Biochemistry 42 (2003) 9952-9958
16. Walker J.E., Lutter R., Dupuis A., and Runswick M.J. Identification of the subunits of F1F0-ATPase from bovine heart mitochondria. Biochemistry 30 (1991) 5369-5378
17. Fearnley I.M., and Walker J.E. Two overlapping genes in bovine mitochondrial DNA encode membrane components of ATP synthase. EMBO J. 5 (1986) 2003-2008
18. Yagi T., and Hatefi Y. Identification of the dicyclohexylcarbodiimide-binding subunit of NADH-ubiquinone oxidoreductase (complex I). J. Biol. Chem. 263 (1988) 16150-16155
19. Chen D.Z., Patel D.V., Hackbarth C.J., Wang W., Dreyer G., Young D.C., et al. Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor. Biochemistry 39 (2000) 1256-1262
20. Giglione C., Vallon O., and Meinnel T. Control of protein life-span by N-terminal methionine excision. EMBO J. 22 (2003) 13-23
21. Ragusa S., Mouchet P., Lazennec C., Dive V., and Meinnel T. Substrate recognition and selectivity of peptide deformylase. Similarities and differences with metzincins and thermolysin. J. Mol. Biol. 289 (1999) 1445-1457
22. Giglione C., and Meinnel T. Organellar peptide deformylases: universality of the N-terminal methionine cleavage mechanism. Trends. Plant Sci. 6 (2001) 566-572
23. Guilloteau J.P., Mathieu M., Giglione C., Blanc V., Dupuy A., Chevrier M., et al. The crystal structures of four peptide deformylases bound to the antibiotic actinonin reveal two distinct types: a platform for the structure-based design of antibacterial agents. J. Mol. Biol. 320 (2002) 951-962
24. Zhou Z., Song X., and Gong W. Novel conformational states of peptide deformylase from pathogenic bacterium Leptospira interrogans: implications for population shift. J. Biol. Chem. 280 (2005) 42391-42396
25. Becker A., Schlichting I., Kabsch W., Groche D., Schultz S., and Wagner A.F. Iron center, substrate recognition and mechanism of peptide deformylase. Nature Struct. Biol. 5 (1998) 1053-1058
26. Chan M.K., Gong W., Rajagopalan P.T., Hao B., Tsai C.M., and Pei D. Crystal structure of the Escherichia coli peptide deformylase. Biochemistry 36 (1997) 13904-13909
27. Meinnel T., Blanquet S., and Dardel F. A new subclass of the zinc metalloproteases superfamily revealed by the solution structure of peptide deformylase. J. Mol. Biol. 262 (1996) 375-386
28. Smith K.J., Petit C.M., Aubart K., Smyth M., McManus E., Jones J., et al. Structural variation and inhibitor binding in polypeptide deformylase from four different bacterial species. Protein Sci. 12 (2003) 349-360
29. Baldwin E.T., Harris M.S., Yem A.W., Wolfe C.L., Vosters A.F., Curry K.A., et al. Crystal structure of type II peptide deformylase from Staphylococcus aureus. J. Biol. Chem. 277 (2002) 31163-31171
30. Kreusch A., Spraggon G., Lee C.C., Klock H., McMullan D., Ng K., et al. Structure analysis of peptide deformylases from Streptococcus pneumoniae, Staphylococcus aureus, Thermotoga maritima and Pseudomonas aeruginosa: snapshots of the oxygen sensitivity of peptide deformylase. J. Mol. Biol. 330 (2003) 309-321
31. Fieulaine S., Juillan-Binard C., Serero A., Dardel F., Giglione C., Meinnel T., and Ferrer J.L. The crystal structure of mitochondrial (type 1A) peptide deformylase provides clear guidelines for the design of inhibitors specific for the bacterial forms. J. Biol. Chem. 280 (2005) 42315-42324
32. Clements J.M., Beckett R.P., Brown A., Catlin G., Lobell M., Palan S., et al. Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor. Antimicrob. Agents Chemother. 45 (2001) 563-570
33. Yoon H.J., Kim H.L., Lee S.K., Kim H.W., Kim H.W., Lee J.Y., et al. Crystal structure of peptide deformylase from Staphylococcus aureus in complex with actinonin, a naturally occurring antibacterial agent. Proteins: Struct. Funct. Genet. 57 (2004) 639-642
34. Schechter I., and Berger A. On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27 (1967) 157-162
35. Schechter I., and Berger A. On the active site of proteases. 3. Mapping the active site of papain; specific peptide inhibitors of papain. Biochem. Biophys. Res. Commun. 32 (1968) 898-902
36. Golovchenko N.P., Kataeva I.A., and Akimenko V.K. Analysis of pH-dependent protein interactions with gel filtration medium. J. Chromatogr. 591 (1992) 121-128
37. Jenkins T.M., Hickman A.B., Dyda F., Ghirlando R., Davies D.R., and Craigie R. Catalytic domain of human immunodeficiency virus type 1 integrase: identification of a soluble mutant by systematic replacement of hydrophobic residues. Proc. Natl Acad. Sci. USA 92 (1995) 6057-6061
38. Zhou Z., Song X., Li Y., and Gong W. Unique structural characteristics of peptide deformylase from pathogenic bacterium Leptospira interrogans. J. Mol. Biol. 339 (2004) 207-215
39. Bingel-Erlenmeyer R., Kohler R., Kramer G., Sandikci A., Antolic S., Maier T., et al. A peptide deformylase-ribosome complex reveals mechanism of nascent chain processing. Nature 452 (2008) 108-111
40. Altschul S.F., Gish W., Miller W., Myers E.W., and Lipman D.J. Basic local alignment search tool. J. Mol. Biol. 215 (1990) 403-410
41. Sharma M.R., Koc E.C., Datta P.P., and Booth T.M. Structure of the mammalian mitochondrial ribosome reveals an expanded functional role for its component proteins. Cell 115 (2003) 97-108
42. Xu Y., Lai L.T., Gabrilove J.L., and Scheinberg D.A. Antitumor activity of actinonin in vitro and in vivo. Clin. Cancer Res. 4 (1998) 171-176
43. Grujic M., Zavasnik-Bergant T., Pejler G., and Renko M. Actinonin induces apoptosis in U937 leukemia cells. Cancer Lett. 223 (2005) 211-218
44. Boularot A., Giglione C., Petit S., Duroc Y., AlvesdeSousa R., Larue V., et al. Discovery and refinement of a new structural class of potent peptide deformylase inhibitors. J. Med. Chem. 50 (2007) 10-20
45. Antczak C., Shum D., Escobar S., Bassit B., Kim E., Seshan V.E., et al. High-throughput identification of inhibitors of human mitochondrial peptide deformylase. J. Biomol. Screen. 12 (2007) 521-535
46. Lazennec C., and Meinnel T. Formate dehydrogenase-coupled spectrophotometric assay of peptide deformylase. Anal. Biochem. 244 (1997) 180-182
47. Otwinowski Z., and Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276 (1997) 307-326
48. Navaza J. AMoRe: an automated package for molecular replacement. Acta Crystallogr. A 50 (1994) 157-163
49. Schwede T., Kopp J., Guex N., and Peitsch M.C. SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res. 31 (2003) 3381-3385
50. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., et al. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D 54 (1998) 905-921
51. Jones T.A., Bergdoll M., and Kjeldgaard M. O: a macromolecular modeling environment. In: Bugg C., and Ealick S. (Eds). Crystallographic and Modeling Methods in Molecular Design (1990), Springer-Verlag Press, New York 189-195
52. Murshudov G.N., Vagin A.A., and Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D 53 (1997) 240-255
53. Thompson J.D., Higgins D.G., and Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22 (1994) 4673-4680
54. Clamp M., Cuff J., Searle S.M., and Barton G.J. The Jalview Java alignment editor. Bioinformatics 20 (2004) 426-427
55. Becker A., Schlichting I., Kabsch W., Schultz S., and Wagner A.F. Structure of peptide deformylase and identification of the substrate binding site. J. Biol. Chem. 273 (1998) 11413-11416
56. Wallace A.C., Laskowski R.A., and Thornton J.M. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 8 (1995) 127-134
57. Weiss M. Global indicators of X-ray data quality. J. Appl. Crystallogr. 34 (2001) 130-135